GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » 3-Year FCF Growth Rate

Avricore Health (Avricore Health) 3-Year FCF Growth Rate : 41.50% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health 3-Year FCF Growth Rate?

Avricore Health's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 41.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 30.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Avricore Health was 76.30% per year. The lowest was -115.70% per year. And the median was 21.00% per year.


Competitive Comparison of Avricore Health's 3-Year FCF Growth Rate

For the Diagnostics & Research subindustry, Avricore Health's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's 3-Year FCF Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Avricore Health's 3-Year FCF Growth Rate falls into.



Avricore Health 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Avricore Health  (OTCPK:AVCRF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Avricore Health 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Avricore Health's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (Avricore Health) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (Avricore Health) Headlines

From GuruFocus

VANC Pharmaceuticals Inc. Provides Corporate Update

By GlobeNewswire GlobeNewswire 11-02-2018

Avricore Health Amends Options

By GlobeNewswire GlobeNewswire 09-11-2020

Avricore Grants Options

By GlobeNewswire GlobeNewswire 08-11-2022

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018

VANC Announces Agreement for Acquisition of Corozon Platform

By GlobeNewswire GlobeNewswire 04-12-2018